Accurate Clinical Research, Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis2 trials
• Giant cell arteritis1 trial
• Polymyalgia rheumatica1 trial

Phase

• Phase 42 trials
• Phase 11 trial

Status

• Completed3 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Novartis Pharmaceuticals1 trial

Closed trials

• Completed

  Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

  NCT06130540· Phase 1· Novartis Pharmaceuticals· Source

• Completed

  A Study of Baricitinib in Participants With Rheumatoid Arthritis

  NCT04086745· Phase 4· Eli Lilly and Company· Source

• Completed

  A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

  NCT03915964· Phase 4· Eli Lilly and Company· Source